BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 6811232)

  • 41. Dose-response relationships for bone cancers from plutonium in dogs and people.
    Muggenburg BA; Mewhinney JA; Griffith WC; Hahn FF; McClellan RO; Boecker BB; Scott BR
    Health Phys; 1983; 44 Suppl 1():529-35. PubMed ID: 6862927
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemopoietic damage and induction of leukemia in offspring due to preconception paternal irradiation from incorporated plutonium-239.
    Lord BI; Hoyes KP
    Radiat Res; 1999 Dec; 152(6 Suppl):S34-7. PubMed ID: 10564933
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Late lesions following incorporation of 224Ra in animal experiment].
    Gössner W; Hindringer B; Hug O; Luz A; Müller WA
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:149-50. PubMed ID: 4344543
    [No Abstract]   [Full Text] [Related]  

  • 44. The specific induction of osteosarcomas in different mouse strains after injections of 239Pu citrate.
    Oghiso Y; Yamada Y
    J Radiat Res; 2003 Jun; 44(2):125-32. PubMed ID: 13678341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relative effectiveness of alpha emitters for bone sarcoma induction.
    Wrenn ME; Lloyd RD; Mays CW; Taylor GN
    Health Phys; 1986 Nov; 51(5):677-82. PubMed ID: 3021652
    [No Abstract]   [Full Text] [Related]  

  • 46. Evaluation of tumor incidence following exposure to internal emitters by application of the logistic dose-response surface.
    Rosenblatt LS; Hetherington NH; Goldman M; Bustad LK
    Health Phys; 1971 Dec; 21(6):869-75. PubMed ID: 5293809
    [No Abstract]   [Full Text] [Related]  

  • 47. The osteosarcomogenic effectiveness of the short-lived 224Ra compared with that of the long-lived 226Ra in mice.
    Müller WA; Luz A
    Radiat Res; 1977 May; 70(2):444-8. PubMed ID: 266221
    [No Abstract]   [Full Text] [Related]  

  • 48. Radiation-induced systemic and local bone tumors: two types of late effects with possible different origins?
    Müller WA; Luz A; Linzner U
    Radiat Res; 1994 Jun; 138(3):415-22. PubMed ID: 8184017
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
    Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Osteosarcoma-inducing effect of plutonium-239 in relation to animal age and sex].
    Siniakov EG
    Radiobiologiia; 1975; 15(6):937-40. PubMed ID: 1062816
    [No Abstract]   [Full Text] [Related]  

  • 52. Myeloid leukaemia and osteosarcoma in CBA/H mice given 224Ra.
    Humphreys ER; Isaacs KR; Raine TA; Saunders J; Stones VA; Wood DL
    Int J Radiat Biol; 1993 Aug; 64(2):231-5. PubMed ID: 8103548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Characteristics of osteosarcomas and morphological changes in the rat thymus during the combined action of gamma-radiation and 239Pu].
    Bukhtoiarova ZM; Spirina SS
    Radiobiologiia; 1989; 29(6):804-8. PubMed ID: 2616758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Incidence of plutonium-induced bone cancer in neutered mice.
    Taylor GN; Gardner P; Mays CW; Wrenn ME; Charrier K
    Cancer Res; 1981 Mar; 41(3):971-3. PubMed ID: 7459884
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Impairment of immunity and long-term effects of 239Pu in rats].
    Kirillova EN; Revina VS; Sokolova SN
    Radiobiologiia; 1991; 31(3):357-60. PubMed ID: 1887001
    [No Abstract]   [Full Text] [Related]  

  • 56. The distribution and pathological effects of Pu in juvenile beagles.
    Bruenger FW; Stevens W; Stover BJ; Taylor GN; Smith JM; Buster DS; Atherton DR
    Radiat Res; 1980 Nov; 84(2):325-42. PubMed ID: 6934561
    [No Abstract]   [Full Text] [Related]  

  • 57. Methods of assay of the relative toxicity of certain bone-seeking radionuclides.
    Gridgeman NT
    Radiat Res; 1971 Nov; 48(2):291-302. PubMed ID: 5286614
    [No Abstract]   [Full Text] [Related]  

  • 58. Radon exposure of the skin: I. Biological effects.
    Charles MW
    J Radiol Prot; 2007 Sep; 27(3):231-52. PubMed ID: 17768326
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of time-factor and RBE for the induction of osteosarcomas by incorporated short-lived bone-seekers.
    Müller WA; Luz A; Schäffer EH; Gössner W
    Health Phys; 1983; 44 Suppl 1():203-12. PubMed ID: 6574999
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Behavior and biological action of large amounts of 239Pu following intramuscular administration in rats undergoing long-term therapy with Zn- and Ca-DTPA].
    Siniakov EG; Bazhin AG; Liubchanskiĭ ER; Nifatov AP
    Radiobiologiia; 1987; 27(1):129-30. PubMed ID: 3469686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.